Introduction to Wells Medical Research Services
Dr. David A. Wells is a pharmaceutical scientist and author in medical information, drug safety, drug metabolism and bioanalytical chemistry, and is also a registered pharmacist. With a career that has included R&D roles, founding and managing a consulting company, university teaching, a leadership role with an outsourced pharmaceutical call center, and continuing his core work as a pharmacist, David possesses a broad range of expertise and knowledge with drugs, their development and support.
Early in his career, David worked with 3M supporting preclinical toxicology studies and Phase I human clinical studies for an antiviral drug (Aldara®). He also utilized pharmacokinetics to interpret data and wrote drug metabolism reports to support three investigational new drug (IND) submissions to the FDA. While at 3M, David was a global Subject Matter Expert (SME) on a novel 3M technology for drug sample preparation named Empore® and he developed and supported products used in pharmaceutical bioanalytical laboratories—Empore® High Performance Extraction Disk Cartridges and 96-Well Solid-Phase Extraction Plates. Over an 8-year period he helped commercialize the Empore technology into a successful business and managed all technical service activities for this product line.
David founded his first consulting company, Sample Prep Solutions, which gave him the opportunity to assist pharmaceutical and contract research laboratories, automation companies, and manufacturers of sample preparation products. Some of the projects David worked on include bioanalytical support for drug discovery projects through Phase III human clinical studies, and a bioterrorism identification kit. David’s assignments have been with well-known companies such as Roche, Bristol-Myers, Takeda, Millennium, Amgen, BioMarin, Shire, Quest Pharmaceutical Services, McNeil Pharma, Merck, Cedra, and Purdue Pharma, to name a few.
In his role with a call center, David managed all aspects of medical information fulfillment for pharmaceutical clients and was a dedicated resource to BioMarin for six years. Activities included responding to every written inquiry for BioMarin, conducting literature searches, writing/editing medical letters, and creating various reports and weekly publication alerts. David is a SME for orphan drugs, lysosomal storage disorders, enzyme replacement therapy, proteasome inhibitors, oncology drugs, and endocrine drugs for growth and maturation.
David’s present role is again in consulting, via his second venture named Wells Medical Research & Support Services. He shares his expertise to medical affairs, medical information, safety and bioanalytical departments to advance their capabilities, lead projects, deliver training and written documents, and provide support in times of reduced headcount. Dr. Wells has a network of associates he calls upon for specific skill sets, so do not hesitate to consider our services for large or more comprehensive projects.
David is active in the education and training of students, acting as a Mentor and Preceptor to colleges of pharmacy at the University of Minnesota and Creighton University, and as an Adjunct Professor in Pharmacology at Northwestern Health Sciences University. Throughout his career, David has continued to maintain his skills with retail pharmacy; these experiences, combined with his research and consulting experiences, give him a thorough understanding of the drug development lifecycle. His experience in toxicology provides valuable knowledge for his work in drug and medical device safety and complaint reporting.
David is the author of the first authoritative reference book on drug sample preparation, High Throughput Bioanalytical Sample Preparation: Methods and Automation Strategies, published by Elsevier in 2003. The second edition of this book has been prepared and is scheduled for release in 2020. He has also contributed to book chapters and written numerous journal articles related to drug sample preparation (see his CV, link below).
David holds a Ph.D. in Toxicology from the University of Kentucky College of Pharmacy and a Bachelor of Science in Pharmacy from Ohio Northern University. He conducted his doctoral thesis on “N-Methyl-2-pyrrolidinone: Radiochemical Synthesis, Disposition and Metabolism in the Rat.” His major professor was Dr. George A. Digenis at the University of Kentucky College of Pharmacy.
David’s interests are diverse, as well. He is interested in alternative healing techniques, and how the brain affects healing and combats disease. He studies Qi Gong, quantum theory and the placebo effect. David is also an artist, where he uses his knowledge of chemistry to change variables in the creative process to achieve outstanding results. His work can be seen at www.DavidWellsArt.com.